Roberto Fuentes

Roberto Fuentes

Auto-generated profile, based on publicly available information

Roberto Fuentes

Chemical Immunology Laboratory, Center for Cooperative Research in Biosciences (CIC Biogune) Basque Research and Technology alliance (BRTA) Derio Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2021 in Nature Reviews Chemistry
Verified
Journal Article
Open access
PDF file
CPCarlo Pifferi
Carlo Pifferi
RFRoberto Fuentes
Roberto Fuentes
AFAlberto Fernández-Tejada
Alberto Fernández-Tejada
Modern subunit vaccines based on homogeneous antigens offer more precise targeting and improved safety compared with traditional whole-pathogen vaccines. However, they are also less immunogenic and require an adjuvant to increase the immunogenicity of the antigen and potentiate the immune response. Unfortunately, few adjuvants have sufficient potency and low enough toxicity for clinical use, highlighting the urgent need for new, potent and safe adjuvants. Notably, a number of natural and synthetic carbohydrate structures have been used as adjuvants in clinical trials, and two have recently been approved in human vaccines. However, naturally derived carbohydrate adjuvants are heterogeneous, difficult to obtain and, in some cases, unstable. In addition, their molecular mechanisms of action are generally not fully understood, partly owing to the lack of tools to elucidate their immune-potentiating effects, thus hampering the rational development of optimized adjuvants. To address these challenges, modification of the natural product structure using synthetic chemistry emerges as an attractive approach to develop well-defined, improved carbohydrate-containing adjuvants and chemical probes for mechanistic investigation. This Review describes selected examples of natural and synthetic carbohydrate-based adjuvants and their application in synthetic self-adjuvanting vaccines, while also discussing current understanding of their molecular mechanisms of action.

14 October 2021 in Chemical Communications
Verified
Journal Article
Open access
PDF file
RFRoberto Fuentes
Roberto Fuentes
LALeire Aguinagalde
Leire Aguinagalde
NSNagore Sacristán
Nagore Sacristán
AFAlberto Fernández-Tejada
Alberto Fernández-Tejada
Versatile chemical strategy for the development of novel conjugates based on streamlined saponin adjuvants covalently linked to a synthetic antigen (Tn) that induced moderate antibody responses in mice.

26 March 2021 in Nature Reviews Chemistry
Verified
Journal Article
Closed access
PDF file
CPCarlo Pifferi
Carlo Pifferi
RFRoberto Fuentes
Roberto Fuentes
AFAlberto Fernández-Tejada
Alberto Fernández-Tejada

28 May 2026 in Chemistry – A European Journal
Verified
Journal Article
Closed access
RFRoberto Fuentes
Roberto Fuentes
PTPriscila Tonon‐Baschirotto
Priscila Tonon‐Baschirotto
LALeire Aguinagalde
Leire Aguinagalde
AFAlberto Fernández‐Tejada
Alberto Fernández‐Tejada